BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21271014)

  • 1. [New paradigms and challenges in cervical cancer prevention and control in Latin America].
    Almonte M; Murillo R; Sánchez GI; Jerónimo J; Salmerón J; Ferreccio C; Lazcano-Ponce E; Herrero R
    Salud Publica Mex; 2010; 52(6):544-59. PubMed ID: 21271014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of HPV testing in Latin America.
    Jeronimo J; Holme F; Slavkovsky R; Camel C
    J Clin Virol; 2016 Mar; 76 Suppl 1():S69-S73. PubMed ID: 26699418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human papilloma virus infection and cervical cancer: a public health perspective].
    Torres-Poveda KJ; Burguete A; Bermúdez-Morales VH; Madrid-Marina V
    Rev Invest Clin; 2008; 60(5):414-20. PubMed ID: 19227439
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
    Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human papillomavirus detection in cervical cancer prevention].
    Picconi MA
    Medicina (B Aires); 2013; 73(6):585-96. PubMed ID: 24356274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cervical cancer screening and the place of the HPV test in 2012].
    Bosch FX; Bergeron C
    Ann Pathol; 2012 Nov; 32(5 Suppl):S22-3. PubMed ID: 23127928
    [No Abstract]   [Full Text] [Related]  

  • 7. Worldwide impact of the human papillomavirus vaccine.
    Hakim AA; Dinh TA
    Curr Treat Options Oncol; 2009 Apr; 10(1-2):44-53. PubMed ID: 19387841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer control in Latin America: A call to action.
    Bychkovsky BL; Ferreyra ME; Strasser-Weippl K; Herold CI; de Lima Lopes G; Dizon DS; Schmeler KM; Del Carmen M; Randall TC; Nogueira-Rodrigues A; de Carvalho Calabrich AF; St Louis J; Vail CM; Goss PE
    Cancer; 2016 Feb; 122(4):502-14. PubMed ID: 26670695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer prevention in Senegal: an International Cooperation Project Report.
    Gabrielli S; Maggioni E; Fieschi L
    Acta Biomed; 2018 Jul; 89(6-S):29-34. PubMed ID: 30038201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in low- and middle-income countries.
    Ditzian LR; David-West G; Maza M; Hartmann B; Shirazian T; Cremer M
    Mt Sinai J Med; 2011; 78(3):319-26. PubMed ID: 21598259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of cervical cancer in Latin America.
    Bosch FX
    Salud Publica Mex; 2016 Apr; 58(2):97-100. PubMed ID: 27557367
    [No Abstract]   [Full Text] [Related]  

  • 14. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
    Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
    Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The impact of the HPV test in screening programs in Latin America: The case of Argentina].
    Arrossi S
    Salud Publica Mex; 2019; 61(1):86-94. PubMed ID: 30753777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
    Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
    Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to cervical cancer screening in Latin America and the Caribbean.
    Herrero R; Ferreccio C; Salmerón J; Almonte M; Sánchez GI; Lazcano-Ponce E; Jerónimo J
    Vaccine; 2008 Aug; 26 Suppl 11():L49-58. PubMed ID: 18945402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M; Sasieni P; Cuzick J
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.